|
Volumn 15, Issue 2, 2009, Pages 209-215
|
Development of ocular myasthenia during pegylated interferon and ribavirin treatment for chronic hepatitis C.
a a a a a |
Author keywords
[No Author keywords available]
|
Indexed keywords
ALPHA2B INTERFERON;
ANTIVIRUS AGENT;
MACROGOL DERIVATIVE;
PEGINTERFERON ALFA-2B;
PEGINTERFERON ALPHA2B;
RIBAVIRIN;
ARTICLE;
CASE REPORT;
CHEMICALLY INDUCED DISORDER;
DRUG COMBINATION;
HEPATITIS C;
HUMAN;
MALE;
MIDDLE AGED;
MYASTHENIA GRAVIS;
ANTIVIRAL AGENTS;
DRUG THERAPY, COMBINATION;
HEPATITIS C, CHRONIC;
HUMANS;
INTERFERON ALFA-2B;
MALE;
MIDDLE AGED;
MYASTHENIA GRAVIS;
POLYETHYLENE GLYCOLS;
RIBAVIRIN;
|
EID: 70350496139
PISSN: 1738222X
EISSN: None
Source Type: Journal
DOI: 10.3350/kjhep.2009.15.2.209 Document Type: Article |
Times cited : (10)
|
References (0)
|